Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

Generic drugmakers in India are revising pricing plans after Denmark’s Novo Nordisk slashed costs for its weight-loss injection Wegovy (semaglutide). Companies that had aimed to launch generics at $84 ...

The particularly harsh winter across much of the country has made the last month particularly difficult for those who suffer from asthma. Exacerbating their distress is the fact that the price of ...

Canada is the first country that is preparing to approve lower-cost generic weight loss drugs. Mr. Funk was the managing ...

Generic drug manufacturers are facing increasing pressure from drug distributors, pharmacy benefit managers, and Indian competitors, leading to downward trends in generic drug prices. Which firms are ...

The post “A Godsend”: ProPublica’s Rx Inspector Tool Is Helping People Find Critical Safety Information on Generic Drugs ...